4.3 Article

The Combination of Flavokawain B and Daunorubicin Induces Apoptosis in Human Myeloid Leukemic Cells by Modifying NF-κB

Journal

ANTICANCER RESEARCH
Volume 38, Issue 5, Pages 2771-2778

Publisher

INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.12520

Keywords

Flavokawain B; daunorubicin; acute myeloid leukemia

Categories

Funding

  1. National R&D Program for Cancer Control, Ministry of Health Welfare, Korea [1520060]
  2. Korea Health Promotion Institute [1520060] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Background/Aim: Flavokawain B (FKB), is a natural chalcone isolated from kava root that induces apoptosis in cancer cells. Herein we investigated the effects of combination of FKB and daunorubicin (DNR) on human leukemic cells. Materials and Methods: Cell viability and death were assessed by the MTS assay and flow cytometry. NK-kappa B was detected by western blotting. Results: FKB alone and in combination with DNR reduced the viable cell numbers of four leukemic cell lines. FKB itself induced apoptosis of an acute myeloid cell line, HL-60. Because the additive effect of DNR and FKB was most obvious in HL-60 cells, subsequent experiments were performed with HL-60 cells. Combined treatment of the two compounds increased NF-kappa B activation at 12 h. Conclusion: A combination treatment of DNR and FKB may improve the anticancer effects of DNR in DNR-resistant acute myeloid leukemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available